BASEL, Switzerland--(BUSINESS WIRE)--Bayer announced today that the company will invest €100 million to further enable sustainable innovation, production and consumption of our Consumer Health products, which include global brands such as Aspirin, Bepanthen, Claritin and Elevit. This investment, which equates to two percent of the division’s sales, will help enable Bayer to drive the sustainable use of the company’s products and help create a world where people can live healthier lives.
Enforcement Report - Week of November 3, 2021
Hetero Labs Unit`s Generic Loratadine Approval In US
The US FDA has approved JB Chemicals & Pharmaceuticals’ Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
NEW DELHI: JB Chemicals and Pharmaceuticals on Friday said it has received approval from the US health regulator to market Loratadine tablets, used to treat allergies, in the American market.
Tenshi's Generic Loratadine Receives Approval In US
Rubicon's Generic Loratadine Receives Approval In US
The FDA on Wednesday said it is requiring a boxed warning and medication guide for Merck’s asthma and allergy drug Singulair (montelukast) and its generics to strengthen existing warnings about the risk of neuropsychiatric events, including suicides, linked to the drug.
The US Food and Drug Administration (FDA) on Wednesday said it is requiring a boxed warning and medication guide for Merck’s asthma and allergy drug Singulair (montelukast) and its generics to strengthen existing warnings about the risk of neuropsychiatric events, including suicides, linked to the drug.
Strides Pharma's Generic Loratadine Receives Approval in U.S